{"id":371770,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2024-08-13] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T15:18:26.159000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2024-08-13.html","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2024-08-13] August 13, 2024 Our file number: 24-107297-36 The purpose of this Notice of Amendment is to notify about the addition of capromorelin (veterinary), eplontersen, lebrikizumab, talquetamab, and zilucoplan…","rawSnapshotUrl":"/api/snapshots/raw/371770","browseUrl":"https://replay.healtharchive.ca/job-6/20260411151826/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2024-08-13.html#ha_snapshot=371770","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}